Herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis: a case report

Induction treatment with rituximab—an anti-CD20 monoclonal antibody—may increase the risk of varicella-zoster virus (VZV) reactivation in patients with antineutrophil-cytoplasmic-antibody-associated vasculitis (AAV). Our case report shows VZV reactivation following rituximab treatment in AAV patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ho-Hsiang, Chen, Hsuan, Lin, Wei-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759945/
https://www.ncbi.nlm.nih.gov/pubmed/36540838
http://dx.doi.org/10.1093/omcr/omac134
_version_ 1784852346608549888
author Chang, Ho-Hsiang
Chen, Hsuan
Lin, Wei-Hung
author_facet Chang, Ho-Hsiang
Chen, Hsuan
Lin, Wei-Hung
author_sort Chang, Ho-Hsiang
collection PubMed
description Induction treatment with rituximab—an anti-CD20 monoclonal antibody—may increase the risk of varicella-zoster virus (VZV) reactivation in patients with antineutrophil-cytoplasmic-antibody-associated vasculitis (AAV). Our case report shows VZV reactivation following rituximab treatment in AAV patients. The recombinant zoster vaccine should be recommended before the start of induction treatment with rituximab.
format Online
Article
Text
id pubmed-9759945
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97599452022-12-19 Herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis: a case report Chang, Ho-Hsiang Chen, Hsuan Lin, Wei-Hung Oxf Med Case Reports Case Report Induction treatment with rituximab—an anti-CD20 monoclonal antibody—may increase the risk of varicella-zoster virus (VZV) reactivation in patients with antineutrophil-cytoplasmic-antibody-associated vasculitis (AAV). Our case report shows VZV reactivation following rituximab treatment in AAV patients. The recombinant zoster vaccine should be recommended before the start of induction treatment with rituximab. Oxford University Press 2022-12-16 /pmc/articles/PMC9759945/ /pubmed/36540838 http://dx.doi.org/10.1093/omcr/omac134 Text en © The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
Chang, Ho-Hsiang
Chen, Hsuan
Lin, Wei-Hung
Herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis: a case report
title Herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis: a case report
title_full Herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis: a case report
title_fullStr Herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis: a case report
title_full_unstemmed Herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis: a case report
title_short Herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis: a case report
title_sort herpes zoster infection after rituximab induction therapy in patient with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759945/
https://www.ncbi.nlm.nih.gov/pubmed/36540838
http://dx.doi.org/10.1093/omcr/omac134
work_keys_str_mv AT changhohsiang herpeszosterinfectionafterrituximabinductiontherapyinpatientwithmyeloperoxidaseantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport
AT chenhsuan herpeszosterinfectionafterrituximabinductiontherapyinpatientwithmyeloperoxidaseantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport
AT linweihung herpeszosterinfectionafterrituximabinductiontherapyinpatientwithmyeloperoxidaseantineutrophilcytoplasmicantibodyassociatedvasculitisacasereport

Ejemplares similares